NDA 202897 describes ACITRETIN, which is a drug marketed by
Alembic,
Barr Labs Inc,
Impax Labs Inc,
Mylan,
Norvium Bioscience,
Sigmapharm Labs Llc, and
Teva Pharms Usa, and is included in seven NDAs. It is available from
eight suppliers. Additional details are available on the
ACITRETIN profile page.
The generic ingredient in ACITRETIN is
acitretin. There are eleven
drug master file entries for this compound. Eight
suppliers are listed for this compound. Additional details are available on the
acitretin profile page.